Motilal Oswal PE to infuse Rs 40 cr in Arinna Lifesciences

Rajesh Kurup Updated - January 24, 2018 at 06:43 PM.

Motilal Oswal Private Equity Advisors (MOPE), a subsidiary of Motilal Oswal Financial Services, has committed to invest Rs 40 crore (Rs 400 million) in Ahmedabad-based Arinna Lifesciences.

The investments would be made through either funds managed or advised by MOPE, the company said in a statement.

“Investments by funds managed or advised by MOPE will help us to expand operations and introduce more products,” said Vivek Seth, founder of Arinna.

This is the first fund-raising for Arinna Lifesciences, a pharma company focusing on the central nervous system therapeutic segment. Bon Proximo acted as advisor to the company.

rajesh.kurup@thehindu.co.in

Published on February 20, 2015 08:45